FTSE All-Share
|
5 851,48
|
31,34
|
0,54 %
|
Analysen zu FTSE All-Share-Werten
| 01.08.25 | BAT Buy | Deutsche Bank AG | |
| 01.08.25 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 01.08.25 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 31.07.25 | Unilever Buy | Deutsche Bank AG | |
| 31.07.25 | HSBC Holdings Neutral | UBS AG | |
| 31.07.25 | GSK Halten | DZ BANK | |
| 31.07.25 | Rio Tinto Hold | Deutsche Bank AG | |
| 31.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 31.07.25 | Glencore Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.07.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 30.07.25 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.07.25 | Glencore Buy | Jefferies & Company Inc. | |
| 30.07.25 | GSK Hold | Jefferies & Company Inc. | |
| 30.07.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 30.07.25 | Diageo Buy | Jefferies & Company Inc. | |
| 30.07.25 | Glencore Outperform | RBC Capital Markets | |
| 30.07.25 | HSBC Holdings Neutral | UBS AG | |
| 30.07.25 | GSK Neutral | UBS AG | |
| 30.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.07.25 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 30.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Glencore Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 30.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 30.07.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.07.25 | Shell Outperform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Diageo Outperform | Bernstein Research | |
| 28.07.25 | National Grid Buy | Jefferies & Company Inc. | |
| 28.07.25 | GSK Outperform | Bernstein Research | |
| 28.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 28.07.25 | London Stock Exchange Buy | UBS AG | |
| 24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.07.25 | Vodafone Group Underperform | Bernstein Research | |
| 24.07.25 | Vodafone Group Neutral | UBS AG | |
| 24.07.25 | Vodafone Group Underweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| Diageo | 13 |
| London Stock Exchange | 9 |
| HSBC Holdings | 7 |
| GSK | 5 |
| Rio Tinto | 1 |
| AstraZeneca | 1 |
| BP | 1 |
| Shell | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.